CD99 in tumor blood vessels inhibits tumor formation [51]; however, CD99 expression is increased in glioblastoma patients, and when divided according to molecular type, CD99 expression is higher in the mesenchymal type than in the pro-neural type. Here, CD99 is linked to glioblastoma.